2 unknown, 1 active not recruiting, 1 completed, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow RNA-Seq: new trials by email Literature Review of RNA-Seq trials Research Report on RNA-Seq
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination IHC: Immunohistochemistry, RNA-seq - Sarcoma, Biomarkers | Active not recruiting | Peking University People's Hospital | 200 | 2025-01-01 | 2025-07-10 | |
| Advanced Translational Research on Childhood Leukemia RNA-seq, whole exon sequencing, Cytogenetics test - Childhood Leukemia | Recruiting | Chinese University of Hong Kong | 300 | 2020-07-01 | 2026-02-03 | |
| Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans cholecalciferol, Standard of Care Prostate Biopsy - collection of 13th core for RNA-seq, Standard of Care Prostate Biopsies at baseline and after one year vitamin D3 supplementation - Prostate Cancer, Vitamin D Deficiency | Phase 2 | Completed | Medical University of South Carolina | 60 | 2019-06-04 | 2025-07-04 |
| Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy RNA sequencing, Transcriptome analysis, target drug with the score above 0,1 - Cancer | Unknown | OmicsWay Corp. | 200 | 2017-10-17 | 2021-09-14 | |
| Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer RNA sequencing, Transcriptome analysis, Trastuzumab - HER2-positive Breast Cancer | Unknown | OmicsWay Corp. | 40 | 2017-10-01 | 2021-09-14 |
Breast Neoplasms (1) · Disease Progression (1) · Fractures, Stress (1) · Neoplasms (1) · Prostatic Neoplasms (1) · Sarcoma (1) · Vitamin D Deficiency (1)
OmicsWay Corp. (2) · Chinese University of Hong Kong (1) · Medical University of South Carolina (1) · Peking University People's Hospital (1)
United States (3) · China (2) · Russia (2)
Anton A Buzdin, Ph.D., D.Sc (1) · Chanita Hughes-Halbert, PhD (1) · Kam Tong Leung, Ph. D. (1)
U54MD010706 (1)